How to Tell If Your Low Blood Pressure Is Dangerously Low? All On Living With Hypotension
Low blood pressure, also known as hypotension, is usually considered a sign of good health and low risk for cardiovascular disease. However, there are times when persistently low blood pressure or a sudden drop can be a sign of an underlying health issue that needs medical attention. Knowing when low blood pressure becomes a problem can help ensure timely intervention and proper care.
Systolic pressure (the top number) indicates the pressure in your arteries when your heart pumps blood. Diastolic pressure (the bottom number) reflects the pressure in your arteries while your heart is resting between beats.
The normal reading is usually 120/80 mmHg or less. Hypotension is clinically defined as having blood pressure readings less than 90/60 mmHg. In some patients, low blood pressure will have no adverse health consequences and therefore does not need to be treated. In extreme cases, however, it can limit the flow of oxygen and nutrients to vital organs, resulting in potentially life-threatening complications, such as shock.
Hypotension can result from many factors. Some of the factors that cause hypotension are as follows:
While low blood pressure may not always cause symptoms, it can sometimes be associated with:
- Dizziness or fainting
- Fatigue and weakness
- Blurred vision
- Nausea
- Confusion or difficulty concentrating
- Shallow breathing
- Palpitations
If the person experiences these symptoms, with the recorded blood pressure reading, the medical services have to be consulted.
1. Orthostatic Hypotension: This is a kind of hypotension that appears as a result of decreased blood pressure when a person is standing up from lying down or sitting position and primarily affects elderly people.
2. Postprandial Hypotension: This is a drop in blood pressure after eating, more common in older people.
3. Neurally Mediated Hypotension: It is triggered by standing for long periods. This type can affect younger people and is associated with miscommunication between the brain and heart.
There is no such thing as a universal threshold for very low blood pressure, but a blood pressure reading below 90/60 mmHg can be dangerous and require prompt medical assessment if accompanied by symptoms of fainting, confusion, or shortness of breath. Sudden falls in blood pressure may point to potentially serious underlying causes, which can include:
Treatment of hypotension depends on its cause:
For more severe cases, physicians might also administer fludrocortisone or midodrine to increase blood pressure. Shock from hypotension should be treated promptly to ensure proper function of organs.
Chronic fatigue syndrome has also been associated with low blood pressure. Prolonged tiredness, despite adequate rest, may require reassessment of blood pressure levels. Fatigue secondary to hypotension will impact functionality and thus requires assessment and treatment of the cause.
If your blood pressure readings are low consistently and without symptoms, you probably have nothing to worry about. If you do have symptoms like dizziness, fainting, or confusion, you need to go to the doctor. Blood pressure checks are usually conducted regularly. Once you are aware of your own normal baseline, you will know right away when there is something wrong.
Credit: Canva
Breast cancer patients who chose to undergo complementary and alternative medicine treatments have the lowest survival rates, a JAMA Oncology study shows.
This form of cancer continues to be the most common cancer among women worldwide, and predicted that the number of new cases of the deadly disease will reach more than 3.5 million globally in 2050 -- rising by a third from 2.3 million in 2023.
The Global Burden of Disease analysis with data from 204 countries revealed that despite advancements in breast cancer treatments, yearly deaths from the disease will rise by 44 percent, from 764,000 to 1.4 million.
About 1.9 lakh Indian women are diagnosed with breast cancer annually, meaning that a new case is diagnosed every four minutes. On average, a woman in India dies of breast cancer every eight minutes, highlighting how urgently the country needs stronger awareness, early diagnosis and sustained care.
One factor that sets India apart is the age at which women are affected. Almost half of all breast cancer patients in the country are younger than 45. This is a much higher proportion than seen in many Western nations, where the disease is usually detected later in life.
Despite multiple advancements in therapies to cure breast cancer, including surgery, chemotherapy, radiation, endocrine therapy, and immunotherapy, a subset of patients continues to choose complementary and alternative medicine (CAM).
However, researchers from Yale University School of Medicine have now found that those who undergo CAM have over three times higher risk of death than those who receive standard therapy.
CAM consists of healthcare practices, products and therapies not generally considered part of conventional Western medicine such as herbal products, vitamins, minerals, meditation, acupuncture, hypnotherapy, tai chi, Reiki and guided imagery.
Using CAM alongside standard treatment was linked to a 45 percent higher risk of death compared with using standard treatment alone, the study noted.
Additionally, women who combined CAM with standard treatment were also less likely to receive key therapies such as hormone therapy or radiation, which worsened their chances of survival and recovery.
In 2023, 28 percent of the global breast cancer burden (6.8 million years of healthy life lost to disability, illness, and early death) was linked to six potentially modifiable risk factors. These include:
Substantial progress has been made in reducing the global breast cancer burden linked to high alcohol use and tobacco between 1990 and 2023, which declined by 47 percent and 28 percent, respectively.
Using artificial intelligence (AI) in breast cancer screening can reduce the number of cancers diagnosed in late stages by 12 percent, according to a major new study from Sweden.
The study found that fewer women in the AI group were diagnosed with breast cancer in the years after screening. There were 1.55 cancers per 1,000 women in the AI-supported group, compared with 1.76 per 1,000 in the standard screening group.
According to lead author Dr Kristina Lang of Lund University in Sweden, this indicates better early identification of clinically relevant cancers. She said of the results: “Our findings show that AI-supported screening improves the early detection of breast cancers that are more likely to become aggressive or advanced.
“This results in fewer serious cancers being diagnosed in the interval between screenings.”
She added that wider adoption of AI-supported mammography could ease workforce pressures on radiologists while improving early detection, including of aggressive cancer subtypes.
As cervical cancer screenings ramp up across the world, a new JAMA study shows that a majority of women prefer clinic-based testing over at-home self-sampling tests in the US.
Researchers from the University of Texas MD Anderson Cancer Center, Houston studied 2,300 women with an average age of 45.5 years. Most were married or living with a partner (58.2 percent), had health insurance (91.9 percent), and had at least some college education (61.6 percent).
Out of those analyzed, over 60 percent preferred clinic-based testing, 20 percent preferred at-home self-sampling tests and over 18 percent were unsure. However, women who had experienced prejudice or discrimination in healthcare were nearly twice as likely to prefer at-home testing.
The study noted that out of the women who preferred at-home testing, nearly 55 percent said it was due to greater privacy, over 35 percent said it was because of a lack of time and over 33 percent noted it was due to fear of embarrassment.
Marginalized women, individuals with low income and individuals who do not trust the health care system were also more likely to prefer at-home self-sampling for cervical cancer screening or not know which option to choose.
To increase screening uptake, the researchers suggested that US officials should incorporate home-based self-sampling as an alternative to clinic-based testing, women’s education and empowerment should be enhanced and tailored interventions focusing on high-risk groups are needed to increase awareness and self-confidence in performing home-based self-sampling.
Cervical cancer develops in a women's cervix (uterus opening) due to abnormal cell growth, primarily caused by persistent HPV infection, a common infection that's passed through sexual contact.
When exposed to HPV, the body's immune system typically prevents the virus from causing damage however, in a small percentage of people, the virus can survive for years and pave the way for some cervical cells to become cancerous.
Treatment involves surgery, radiation, and chemotherapy, with early detection significantly improving outcomes, though it remains a major cancer in low-income countries Cervical cancer can also be prevented through vaccination and regular screening (Pap/HPV tests).
Cervical cancer has no symptoms in the early days and therefore, is hard to detect until it has spread. However, the early-stage symptoms include:
As per the World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus, about 42,000 new cases of cervical cancer is reported annually in India. This underscores the need for preventive measures such as vaccination and early screening. The country loses one women every eight minutes to cervical cancer.
The WHO Global Strategy to eliminate cervical cancer includes the 90-70-90 targets by 2030 -- vaccinating 90 per cent of girls against HPV, screening 70 percent of women, and ensuring treatment for 90 percent of those diagnosed with cervical disease.
In line with the global strategy to fight cervical cancer, Prime Minister Narendra Modi recently also launched a free HPV vaccination drive that will target health and well-being of adolescent girls in the country.
Union Health Minister JP Nadda has also announced that cervical cancer screenings using Visual Inspection with Acetic Acid (VIA) will now be available at Ayushman Arogya Mandirs and other health facilities for women between 30 and 65 years of age.
"Screening for cervical cancer is now available at 1,81,000 Ayushman Arogya Mandirs, also known as Health and Wellness Centers, across the country as a part of population based screening for early detection and treatment," said Nadda, while addressing a press briefing at the World Health Organization virtually.
Using VIA, a low-cost, point-of-care method, trained health workers will screen women for cervical cancer. Those who test positive will then be referred to higher centers for diagnostic confirmation and further evaluation.
Credit: Canva
Viagra, a popular erectile dysfunction medication, may be the world's only existing treatment against Alzheimer's disease, according to over 20 experts.
A panel of 21 experts recently combed through anonymous nominations, clinical evidence and found that out of 80 existing medications that show potential in treating the neurodegenerative disorder.
Out of those, Sildenafil (Viagra) ranked first, with Zostavax (a shingles vaccine) and Riluzole (a drug used to treat amyotrophic lateral sclerosis) coming in second and third.
"Each of the priority candidates has evidence supporting relevant underlying mechanisms of action, non-clinical studies, and clinical evidence from epidemiological studies and/or preliminary clinical trials," the researchers wrote in their paper.
"The tolerability of each of these compounds is also suitable for administration to a frailer population of older individuals as part of a well-monitored clinical trial program. We therefore recommend each of these therapeutic approaches as a high priority for clinical trials for the treatment or prevention of Alzheimer's disease."
The researchers found that Viagra may support brain health in several ways. Studies suggest it can promote the growth of nerve extensions (neurites) and reduce abnormal tau protein activity as well as improve blood flow and oxygen supply to the brain.
Previous research also shows that the compound can reduce levels of amyloid-beta (Aβ42) in the hippocampus and lower markers of brain inflammation. Additionally, it can also protect neurons from amyloid-beta damage.
Scientists are yet to determine the exact mechanism behind how Viagra can help protect the brain from Alzheimer's-related damage.
Alzheimer's disease is one of the most common forms of dementia and mostly affects adults over the age of 65.
About 8.8 million Indians aged 60 and above are estimated to be living with Alzheimer's disease. Over seven million people in the US 65 and older live with the condition and over 100,00 die from it annually.
Alzheimer's disease is believed to be caused by the development of toxic amyloid and beta proteins in the brain, which can accumulate in the brain and damage cells responsible for memory.
Amyloid protein molecules stick together in brain cells, forming clumps called plaques. At the same time, tau proteins twist together in fiber-like strands called tangles. The plaques and tangles block the brain's neurons from sending electrical and chemical signals back and forth.
Over time, this disruption causes permanent damage in the brain that leads to Alzheimer's disease and dementia, causing patients to lose their ability to speak, care for themselves or even respond to the world around them.
While there is no clear cause of Alzheimer's disease, experts believe it can develop due to genetic mutations and lifestyle choices, such as physical inactivity, unhealthy diet and social isolation.
Early symptoms of Alzheimer's disease include forgetting recent events or conversations. Over time, Alzheimer's disease leads to serious memory loss and affects a person's ability to do everyday tasks.
There is no cure for this progressive brain disorder and in advanced stages, loss of brain function can cause dehydration, poor nutrition or infection. These complications can result in death.
The US Food and Drug Administration has approved the use of a blood test which can help diagnose Alzheimer’s disease in adults aged 55 and above.
The blood test, known as Lumipulse, can detect amyloid plaques associated with Alzheimer’s disease and has proven to be a “less invasive option” that “reduces reliance on PET scans and increases diagnosis accessibility.”
FDA Commissioner Martin A. Makary said of the landmark decision, "Alzheimer’s disease impacts too many people, more than breast cancer and prostate cancer combined.
"Knowing that 10 percent of people aged 65 and older have Alzheimer's, and that by 2050 that number is expected to double, I am hopeful that new medical products such as this one will help patients."
It remains unclear when this test will be available for commercial use across the world.
© 2024 Bennett, Coleman & Company Limited